Sudan and South Sudan Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Sudan and South Sudan Pharmaceuticals and Healthcare Report Q3 2013 May 15th 2013, 00:00 BMI View: Sudan will remain one of the least attractive countries in the Middle East/Africa region due to low pharmaceutical and healthcare expenditure. The government’s low commitment to healthcare, combined with political and economic uncertainties, will remain a downside risk to the future growth potential of the pharmaceutical industry. Headline Expenditure Projections ? Pharmaceuticals: SDG1.92bn (US$540mn) in 2012 to SDG2.38bn (US$510mn) in 2013; +24.0% in local currency terms with a contraction of -6.8% in US dollar terms. Forecast in line with Q213, growth contractions in US dollar terms due to currency fluctuations. ? Healthcare: SDG14.49bn (US$4.10bn) in 2012 to SDG19.45bn … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=96092. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/sudan-and-south-sudan-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions